AF
RPRX icon

Allworth Financial’s Royalty Pharma RPRX Stock Holding History

Allworth Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
7,456
+1,564
+27% +$81.4K ﹤0.01% 1074
2026
Q1 		$283K Buy
5,892
+2,627
+80% +$115K ﹤0.01% 1211
2025
Q4 		$126K Buy
3,265
+199
+6% +$7.59K ﹤0.01% 1607
2025
Q3 		$108K Buy
3,066
+204
+7% +$7.38K ﹤0.01% 1642
2025
Q2 		$103K Buy
2,862
+1,323
+86% +$43.8K ﹤0.01% 1535
2025
Q1 		$49.3K Buy
1,539
+452
+42% +$14.3K ﹤0.01% 1557
2024
Q4 		$32.7K Buy
1,087
+877
+418% +$23.3K ﹤0.01% 1795
2024
Q3 		$5.93K Buy
210
+69
+49% +$1.91K ﹤0.01% 2495
2024
Q2 		$3.98K Sell
141
-1,531
-92% -$42.4K ﹤0.01% 2622
2024
Q1 		$50.8K Sell
1,672
-12
-0.7% -$354 ﹤0.01% 1301
2023
Q4 		$47.3K Buy
1,684
+731
+77% +$20.1K ﹤0.01% 1222
2023
Q3 		$25.9K Buy
953
+451
+90% +$13.4K ﹤0.01% 1378
2023
Q2 		$15.4K Sell
502
-17
-3% -$576 ﹤0.01% 1695
2023
Q1 		$18.7K Buy
519
+161
+45% +$5.97K ﹤0.01% 1489
2022
Q4 		$14.1K Sell
358
-27
-7% -$1.13K ﹤0.01% 1555
2022
Q3 		$15K Sell
385
-9
-2% -$384 ﹤0.01% 1419
2022
Q2 		$17K Buy
394
+382
+3,183% +$15.7K ﹤0.01% 1312
2022
Q1 		$0 Buy
+12
New +$471 ﹤0.01% 2345

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's RPRX Position: Q2 2026 in Review

Allworth Financial increased its Royalty Pharma (RPRX) stake by 27% in Q2 2026, buying an estimated $81.4K and bringing the position to 7,456 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

Allworth Financial first reported a position in RPRX in Q1 2022 and has held it in 18 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Allworth Financial held 7,456 shares of Royalty Pharma worth $418K as of Q2 2026.
  • Allworth Financial bought 1,564 Royalty Pharma shares in Q2 2026, an estimated $81.4K.
  • Royalty Pharma made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1074 holding.
  • Allworth Financial first reported a position in Royalty Pharma in Q1 2022 and has held it in 18 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.